Dr. Alain Litwin, MD
Claim this profileGreenville Health System
Studies Opioid Use Disorder
Studies Substance Use Disorders
7 reported clinical trials
11 drugs studied
Affiliated Hospitals
Clinical Trials Alain Litwin, MD is currently running
Care Coordination with Peer Support
for Hepatitis C
The overarching goal of this study is to develop a peer-based care coordination intervention for individuals with HCV who were recently released from correctional settings to promote linkage to and retention in HCV care. The investigators will assess the existing barriers and facilitators of HCV treatment initiation, HCV treatment completion, and sustained virologic response among individuals recently released from a U.S. jail or prisons in a randomized control trial. This study will assess the feasibility and process measures of a peer-enhanced HCV care coordination intervention among recently incarcerated individuals.
Recruiting0 awards N/A
INDV-2000
for Opioid Use Disorder
The purpose of this study is to measure safety and efficacy and to determine dose-response relationship for INDV-2000 in participants with moderate to severe Opioid Use Disorder (OUD) who are new to treatment, have recently initiated or completed short-term medically supervised withdrawal with transmucosal (TM) buprenorphine, and are interested in transitioning to a non opioid treatment.
Recruiting0 awards Phase 23 criteria
More about Alain Litwin, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Alain Litwin, MD has experience with
- Extended-release Buprenorphine
- Transmucosal Buprenorphine
- SUBLOCADE
- INDV-2000
- CBT4CBT
- RC
Breakdown of trials Alain Litwin, MD has run
Opioid Use Disorder
Substance Use Disorders
- SUBLOCADE Long-term Outcomes
- INDV-2000 for Opioid Use Disorder
- Development, Refinement, and Validation of a Peer Support Specialist Checklist for Individuals With Opioid Use Disorder / STAMPS: South Carolina Buprenorphine Treatment Initiation, Adherence, and Retention Utilizing Mobile Health Units and Peer Support Specialists
Cognitive Behavioral Therapy
Opioid Overdose
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alain Litwin, MD specialize in?
Alain Litwin, MD focuses on Opioid Use Disorder and Substance Use Disorders. In particular, much of their work with Opioid Use Disorder has involved treating patients, or patients who are undergoing treatment.
Is Alain Litwin, MD currently recruiting for clinical trials?
Yes, Alain Litwin, MD is currently recruiting for 3 clinical trials in Greenville South Carolina. If you're interested in participating, you should apply.
Are there any treatments that Alain Litwin, MD has studied deeply?
Yes, Alain Litwin, MD has studied treatments such as Extended-release Buprenorphine, Transmucosal Buprenorphine, SUBLOCADE.
What is the best way to schedule an appointment with Alain Litwin, MD?
Apply for one of the trials that Alain Litwin, MD is conducting.
What is the office address of Alain Litwin, MD?
The office of Alain Litwin, MD is located at: Greenville Health System, Greenville, South Carolina 29605 United States. This is the address for their practice at the Greenville Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.